📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
JUBILANT PHARMOVA LIMITEDJUBLPHARMAPharmaceuticals
Open
968
High
969.5
Low
926.9
Close
956.1
Volume
139598
Exchange
nse
Time
23-Jan-2026

Outlook

Score:

1.25

Rating:

RISKY

Candlestick Pattern

CandlepatternofJubilantPharmovais
None
EstimatedStoplossofJubilantPharmovais
969.5
JubilantPharmovahasa
Bearishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofJubilantPharmovais
Unpredictableℹ
.

Trend

JubilantPharmovaisin
Sideways trendℹ
.
PriceofJubilantPharmovais
Downℹ
by

9.48

%.
Target
Buy@

981.98

Sell@

1175.56

Current@

956.1

Volume

ThetradevolumesofJubilantPharmovahavebeen
Underperformingℹ
ThevolumetrendforJubilantPharmovais
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofJubilantPharmovais

Down

by

7.04

%

Valuation

ThecurrentmarketpriceofJubilantPharmovais
Overvaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth12756crandtotalassetsworth12756cr,thebalancesheetofJubilantPharmovais:
Balancedℹ
.
Cashflow
JubilantPharmovahas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 131cr

.Itis
Upℹ
by

329.82

%.
35.32% i.e. ₹ 1072cr earned in operatingℹ
16.05% i.e. ₹ 487cr earned in investingℹ
47.84% i.e. ₹ 1452cr spent in financingℹ
0.79% i.e. ₹ 24cr earned in otherℹ
JubilantPharmovahas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 57cr

.Itis
Downℹ
by

290

%.
48.05% i.e. ₹ 971cr earned in operatingℹ
30.03% i.e. ₹ 607cr spent in investingℹ
21.38% i.e. ₹ 432cr spent in financingℹ
0.54% i.e. ₹ 11cr earned in otherℹ
Income
TheincomeofJubilantPharmovais

₹ 1976cr

and

Profit

is:

₹ 120cr

JubilantPharmovaProfitisupby:

17.65

%andIncomeisUpby:

3.35

%
TheincomeofJubilantPharmovais

₹ 1912cr

and

Profit

is:

₹ 102cr

JubilantPharmovaProfitisdownby:

32.45

%andIncomeisDownby:

1.44

%
TheincomeofJubilantPharmovais

₹ 1940cr

and

Profit

is:

₹ 151cr

JubilantPharmovaProfitisupby:

49.5

%andIncomeisUpby:

6.01

%
By using this site you agree to the use of cookies to deliver a better site experience.